Invention Grant
US08623359B2 Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
有权
c-Met拮抗剂与氨基杂芳基化合物的组合用于治疗癌症
- Patent Title: Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
- Patent Title (中): c-Met拮抗剂与氨基杂芳基化合物的组合用于治疗癌症
-
Application No.: US13002875Application Date: 2009-07-08
-
Publication No.: US08623359B2Publication Date: 2014-01-07
- Inventor: Liliane Goetsch
- Applicant: Liliane Goetsch
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Pierre Fabre Medicament
- Current Assignee: Pierre Fabre Medicament
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Priority: EP08305387 20080708
- International Application: PCT/EP2009/058709 WO 20090708
- International Announcement: WO2010/003992 WO 20100114
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention also relates to a composition comprising an antibody antagonist to c-Met and an aminoheteroaryl compound, particularly as a medicament. The present invention also comprises a pharmaceutical composition comprising said anti c-Met antibody and said aminoheteroaryl compound as combination products for simultaneous, separate or sequential use. The invention relates to the use of the composition of the invention for the treatment of cancer in a mammal.
Public/Granted literature
- US20110117098A1 COMBINATION OF A C-MET ANTAGONIST AND AN AMINOHETEROARYL COMPOUND FOR THE TREATMENT OF CANCER Public/Granted day:2011-05-19
Information query
